RISK FACTORS FOR LOCOREGIONAL FAILURE IN COMPLETELY RESECTED N1 NON-SMALL CELL LUNG CANCER WITHOUT POSTOPERATIVE RADIOTHERAPY

被引：0
作者：
Cho, Sukki [1 ]
Park, Samina [2 ]
Jheon, Sanghoon [1 ]
Kim, Kwhanmien [1 ]
Yang, Hee Chul [1 ]
Yi, Eunjue [1 ]
Seok, Yangki [1 ]
Noh, Dongsub [1 ]
Yeom, Sung Won [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seoul 151, South Korea
[2] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Non small cell lung cancer; N1; disease; Recurrence; risk factors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.07-013
引用
收藏
页码：S813 / S814
页数：2
相关论文
共 50 条
  • [41] Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients
    Gao, Fei
    Li, Nan
    Xu, YongMei
    Yang, GuoWang
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [42] Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer
    Osaki, T
    Nagashima, A
    Yoshimatsu, T
    Tashima, Y
    Yasumoto, K
    LUNG CANCER, 2004, 43 (02) : 151 - 157
  • [43] Radiotherapy for locoregional recurrent tumors after resection of non-small cell lung cancer
    Kagami, Y
    Nishio, M
    Narimatsu, N
    Mjoujin, M
    Sakurai, T
    Hareyama, M
    Saito, A
    LUNG CANCER, 1998, 20 (01) : 31 - 35
  • [44] Patterns of failure after postoperative radiotherapy for incompletely resected (R1) non-small cell lung cancer: Implications for radiation target volume design
    Olszyna-Serementa, Marta
    Socha, Joanna
    Wierzchowski, Marek
    Kepka, Lucyna
    LUNG CANCER, 2013, 80 (02) : 179 - 184
  • [45] Risk factors for recurrence after complete resection of pathological stage N2 non-small cell lung cancer
    Qiang, Guangliang
    Liang, Chaoyang
    Yu, Qiduo
    Xiao, Fei
    Song, Zhiyi
    Tian, Yanchu
    Shi, Bin
    Liu, Deruo
    Guo, Yongqing
    THORACIC CANCER, 2015, 6 (02) : 166 - 171
  • [46] Predicting Postoperative Recurrence in Completely Resected EGFR-Mutant Non-Small Cell Lung Cancer: Value of IHC Markers
    Guo, T.
    Ni, J.
    Li, Y.
    Zhu, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S240 - S241
  • [47] Adjuvant Chemotherapy is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Nakata, M.
    Nojima, Y.
    Nanba, K.
    Saisho, S.
    Shimizu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S845 - S846
  • [48] Prognostic Factors and the Significance of Treatment After Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer
    Shimada, Yoshihisa
    Saji, Hisashi
    Yoshida, Koichi
    Kakihana, Masatoshi
    Honda, Hidetoshi
    Nomura, Masaharu
    Usuda, Jitsuo
    Kajiwara, Naohiro
    Ohira, Tatsuo
    Ikeda, Norihiko
    CHEST, 2013, 143 (06) : 1626 - 1634
  • [49] Postoperative Radiotherapy for Incompletely Resected Non-small Cell Lung Cancer: Clinical Outcomes and Prognostic Value of the Histological Subtype
    Ohguri, Takayuki
    Yahara, Katsuya
    Moon, Seung Dae
    Yamaguchi, Shinsaku
    Imada, Hajime
    Hanagiri, Takeshi
    Tanaka, Fumihiro
    Terashima, Hiromi
    Korogi, Yukunori
    JOURNAL OF RADIATION RESEARCH, 2012, 53 (02) : 319 - 325
  • [50] Surveillance of resected non-small cell lung cancer
    A. López-González
    P. Ibeas Millán
    B. Cantos
    M. Provencio
    Clinical and Translational Oncology, 2012, 14 : 721 - 725
12345